Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy-Reference-Cited by-同舟云学术

Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy

Published:2022-04 Issue:4 Volume:11 Page:
ISSN:2001-3078
Container-title:Journal of Extracellular Vesicles
language:en
Short-container-title:J of Extracellular Vesicle

Author:

Peng Boya¹²^ORCID,Nguyen Trinh Mai³⁴,Jayasinghe Migara Kavishka¹²,Gao Chang¹²,Pham Thach Tuan¹²,Vu Luyen Tien¹²,Yeo Eric Yew Meng¹²,Yap Gracemary¹²,Wang Lingzhi⁵,Goh Boon Cher⁵,Tam Wai Leong⁵⁶,Luo Dahai³⁴,Le Minh TN¹²^ORCID

Affiliation:

1. Department of Pharmacology and Institute for Digital Medicine Yong Loo Lin School of Medicine National University of Singapore Singapore

2. Department of Surgery Immunology Program Cancer Program and Nanomedicine Translational Program Yong Loo Lin School of Medicine National University of Singapore Singapore

3. Lee Kong Chian School of Medicine Nanyang Technological University Singapore

4. NTU Institute of Structural Biology Nanyang Technological University Singapore

5. Cancer Science Institute of Singapore National University of Singapore Singapore

6. Genome Institute of Singapore, A*STAR Singapore

Funder

National University of Singapore

Publisher

Wiley

Subject

Cell Biology,Histology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jev2.12187

Reference48 articles.

1. Improving in Vivo Hepatic Transfection Activity by Controlling Intracellular Trafficking: The Function of GALA and Maltotriose

2. Proapoptotic signaling induced by RIG‐I and MDA‐5 results in type I interferon–independent apoptosis in human melanoma cells;Besch R.;The Journal of Clinical Investigation,2009

3. Cell-Type-Specific Innate Immune Response to Oncolytic Newcastle Disease Virus

4. Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists

5. RNA therapeutics: RNAi and antisense mechanisms and clinical applications

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances with erythrocytes as therapeutics carriers;International Journal of Pharmaceutics;2024-11

2. Expression of the αVβ3 integrin affects prostate cancer sEV cargo and density and promotes sEV pro‐tumorigenic activity in vivo through a GPI‐anchored receptor, NgR2;Journal of Extracellular Vesicles;2024-08

3. An Update of Extracellular Vesicle Involvement in Different Steps of Cancer Metastasis and Targeting Strategies;Current Medicinal Chemistry;2024-08

4. Extracellular vesicle surface display enhances the therapeutic efficacy and safety profile of cancer immunotherapy;Molecular Therapy;2024-07

5. Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer;Cancers;2024-06-12